Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: COVID-19 ChAdOx1-S Viral Vector Vaccine (AstraZeneca) TM

Active ingredients: covid-19 viral vector vaccine

What it is used for

VAXZEVRIA has provisional approval for the indication:,Active immunisation of individuals greater than or equal to 18 years old for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.,The use of this vaccine should be in accordance with official recommendations.,The decision has been made on the basis of short term efficacy and safety data. Continued approval is dependent upon the evidence of longer-term efficacy and safety from ongoing clinical trials and post-market assessment.

How to take it

The way to take this medicine is: Intramuscular. This medicine is given through a needle inserted into the muscle beneath the skin.

  • Store at 2 to 8 degrees Celsius
  • Do not Freeze
  • Do not Shake
  • Store in Original Container
  • Protect from Light
  • Shelf lifetime is 9 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Clear to slightly opaque, colourless to slightly brown, particle free solution in clear glass vial, elastomeric stopper & aluminium overseal

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

Pregnant or planning a pregnancy?

For the active ingredient covid-19 viral vector vaccine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.


Reporting side effects

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.

Back to top back to top

Need more information?

These trusted information partners have more on this topic.

Top results

Vaxzevria (AstraZeneca) vaccine and thrombosis with thrombocytopenia (TTS) | Australian Government Department of Health and Aged Care

Thrombosis with thrombocytopenia (TTS) is a rare syndrome that occurred in around 2 to 3 people per 100,000 who were vaccinated with AstraZeneca. AstraZeneca is no longer available in Australia from 21 March 2023.

Read more on Department of Health and Aged Care website

COVID-19 vaccine development landscape | NCIRS

COVID-19 vaccine development landscape COVID-19 Aboriginal and Torres Strait Islander immunisation Australian Immunisation Handbook AusVaxSafety Clinical research COSSI COVID-19 NCIRS COVID-19 response COVID-19 vaccine development landscape COVID-19 vaccines: Frequently asked questions COVID-19 and children: Frequently asked questions Serosurveillance for SARS-CoV-2 COVID-19 vaccination program in Australia COVID-19 in educational settings Disease surveillance and epidemiology Education and training New South Wales Immunisation Specialist Service (NSWISS) Paediatric Active Enhanced Disease Surveillance (PAEDS) PHN Immunisation Support program Population health Program evaluation Regional and global collaborations Research to inform policy Sharing Knowledge About Immunisation (SKAI) Serosurveillance Social science in immunisation Vaccine coverage Vaccine safety In response to the COVID-19 pandemic, our policy support team has been closely monitoring publicly available information on COVID-19 vaccine candidates

Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website

Frequently Asked Questions about COVID-19 vaccines for people affected by cancer | Cancer Australia

Cancer Australia has compiled answers to Frequently Asked Questions (FAQs) about COVID-19 vaccines for people affected by cancer based on information and evidence currently available in Australia and internationally.

Read more on Cancer Australia website

COVID-19 vaccination when pregnant or breastfeeding and for those planning pregnancy - RANZCOG

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) acknowledges the risk posed to the community, healthcare workers, and all patients, due to the COVID-19 (coronavirus) pandemic

Read more on RANZCOG - Royal Australian and New Zealand College of Obstetricians and Gynaecologists website

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Queensland Government logo Government of South Australia, health department logo Tasmanian government logo Victorian government logo Government of Western Australia, health department logo

Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and present.